152 related articles for article (PubMed ID: 12781328)
1. Non-caspase-mediated apoptosis contributes to the potent cytotoxicity of the enediyne antibiotic lidamycin toward human tumor cells.
Wang Z; He Q; Liang Y; Wang D; Li YY; Li D
Biochem Pharmacol; 2003 Jun; 65(11):1767-75. PubMed ID: 12781328
[TBL] [Abstract][Full Text] [Related]
2. [Characterization of cell death induced by anticancer antibiotic lidamycin in human hepatoma BEL-7402 cells].
He QY; Liang YY; Wang DS; Li DD
Yao Xue Xue Bao; 2001 Mar; 36(3):174-8. PubMed ID: 12580082
[TBL] [Abstract][Full Text] [Related]
3. [Effect of lidamycin on mitochondria initiated apoptotic pathway in human cancer cells].
Qiu Q; Wang Z; Jiang JM; Li DD
Yao Xue Xue Bao; 2007 Feb; 42(2):132-8. PubMed ID: 17518039
[TBL] [Abstract][Full Text] [Related]
4. P53 dependent and independent apoptosis induced by lidamycin in human colorectal cancer cells.
Chen L; Jiang J; Cheng C; Yang A; He Q; Li D; Wang Z
Cancer Biol Ther; 2007 Jun; 6(6):965-73. PubMed ID: 17534142
[TBL] [Abstract][Full Text] [Related]
5. [Effects of lidamycin on apoptotic gene expressions and cytoskeleton in human hepatoma bel-7402 cells].
He QY; Jiang B; Li DD; Zhen YS
Ai Zheng; 2002 Apr; 21(4):351-5. PubMed ID: 12452009
[TBL] [Abstract][Full Text] [Related]
6. Hsp90 inhibitor geldanamycin enhances the antitumor efficacy of enediyne lidamycin in association with reduced DNA damage repair.
Han FF; Li L; Shang BY; Shao RG; Zhen YS
Asian Pac J Cancer Prev; 2014; 15(17):7043-8. PubMed ID: 25227788
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of mitotic cell death induced by enediyne antibiotic lidamycin in human epithelial tumor cells.
He QY; Liang YY; Wang DS; Li DD
Int J Oncol; 2002 Feb; 20(2):261-6. PubMed ID: 11788886
[TBL] [Abstract][Full Text] [Related]
8. [Potentiation and mechanism of cisplatin-induced apoptosis by lidamycin in human hepatoma BEL-7402 cells].
Liu HZ; Li DD; Zhen YS; Shao RG
Yao Xue Xue Bao; 2003 Apr; 38(4):250-4. PubMed ID: 12889121
[TBL] [Abstract][Full Text] [Related]
9. Enediyne lidamycin induces apoptosis in human multiple myeloma cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase.
Zhen YZ; Lin YJ; Shang BY; Zhen YS
Int J Hematol; 2009 Jul; 90(1):44-51. PubMed ID: 19468799
[TBL] [Abstract][Full Text] [Related]
10. Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule.
Huang YH; Shang BY; Zhen YS
World J Gastroenterol; 2005 Jul; 11(26):3980-4. PubMed ID: 15996019
[TBL] [Abstract][Full Text] [Related]
11. Effect of lidamycin on telomerase activity in human hepatoma BEL-7402 cells.
Gao RJ; Liang YX; Li DD; Zhang HY; Zhen YS
Biomed Environ Sci; 2007 Jun; 20(3):189-97. PubMed ID: 17672208
[TBL] [Abstract][Full Text] [Related]
12. Effects of lidamycin on genomic DNA in human hepatoma BEL-7402 cells.
He QY; Jiang B; Li DD
Acta Pharmacol Sin; 2002 Mar; 23(3):253-6. PubMed ID: 11918851
[TBL] [Abstract][Full Text] [Related]
13. Difference of cell cycle arrests induced by lidamycin in human breast cancer cells.
Liu X; He H; Feng Y; Zhang M; Ren K; Shao R
Anticancer Drugs; 2006 Feb; 17(2):173-9. PubMed ID: 16428935
[TBL] [Abstract][Full Text] [Related]
14. Role of prosurvival molecules in the action of lidamycin toward human tumor cells.
Yang AJ; Shi WW; Li Y; Wang Z; Shao RG; Li DD; He QY
Biomed Environ Sci; 2009 Jun; 22(3):244-52. PubMed ID: 19725468
[TBL] [Abstract][Full Text] [Related]
15. [Antitumor effect of lidamycin-containing monoclonal antibody immunoconjugate with downsized-molecule].
Liu XY; Zhen YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):563-7. PubMed ID: 12901099
[TBL] [Abstract][Full Text] [Related]
16. Mitotic cell death in BEL-7402 cells induced by enediyne antibiotic lidamycin is associated with centrosome overduplication.
Liang YX; Zhang W; Li DD; Liu HT; Gao P; Sun YN; Shao RG
World J Gastroenterol; 2004 Sep; 10(18):2632-6. PubMed ID: 15309709
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activities of dFv-LDP-AE: An enediyne-energized fusion protein targeting tumor-associated antigen gelatinases.
Zhong GS; Wu MN; Guo XF; Zhang SH; Miao QF; Zhen YS
Oncol Rep; 2012 Oct; 28(4):1193-9. PubMed ID: 22797730
[TBL] [Abstract][Full Text] [Related]
18. [Synergistic effect and its possible mechanisms of lidamycin in combination with TRAIL in NSCLC].
Yang J; Chen SZ
Yao Xue Xue Bao; 2010 Oct; 45(10):1247-53. PubMed ID: 21348302
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
Chen J; Ouyang ZG; Zhang SH; Zhen YS
Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin.
Zhang C; Guo LY; Mu D; Gong JH; Chen J
Oncol Rep; 2019 Jan; 41(1):475-482. PubMed ID: 30542729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
